News | October 16, 2025
IOL Chemicals receives EDQM certificate for Pantoprazole Sodium Sesquihydrate Process-III
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial) have an estimated market size of US$ 48 million for twelve months ending December 2024 according to IQVIA
EDQM has also issued a Certificate of Suitability for Allopurino
Pantoprazole Sodium Delayed-Release Tablets are indicated for short-term treatment of Erosive Esophagitis associated with GERD
Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion
This approval authorizes the company to export Ibuprofen to the Chinese markets
The launch of Chlorpromazine Hydrochloride for Injection is the latest in a series of recent product launches from Piramal Critical Care
The company reported total income at Rs. 509.8 crore in Q1 FY25 as compared to Rs. 570.3 crore in Q1 FY24
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
The National Institute of Pharmacy and Nutrition, Hungary has issued 'Certificate of GMP Compliance of Manufacturer' for IOL Chemicals and Pharmaceuticals Limited's products.
Subscribe To Our Newsletter & Stay Updated
